InBody Co (XKRX:041830) Construction In Progress: ₩2,854 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKRX:041830 InBody Co Ltd XKRX:041830
86 GF Score
Price ₩58,900.00
GF Value ₩35,473.99
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is InBody Co Construction In Progress?

InBody Co XKRX:041830 -3.60% 86 Construction In Progress is ₩2,854 Mil as of Jun. 2026. GuruFocus rates XKRX:041830 with a GF Score™ of 86/100 and a GF Value™ of ₩35,473.99 (Significantly Overvalued). The stock has 1 warning sign investors should review.

InBody Co's quarterly construction in progress declined from Dec. 2025 (₩3,370 Mil) to Mar. 2026 (₩2,659 Mil) but then increased from Mar. 2026 (₩2,659 Mil) to Jun. 2026 (₩2,854 Mil).

InBody Co's annual construction in progress declined from Dec. 2023 (₩412 Mil) to Dec. 2024 (₩347 Mil) but then increased from Dec. 2024 (₩347 Mil) to Dec. 2025 (₩3,370 Mil).

InBody Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for InBody Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InBody Co Construction In Progress Chart

InBody Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.80 2,556.20 412.46 346.89 3,370.30

InBody Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,372.37 3,803.01 3,370.30 2,659.44 2,853.94
XKRX:041830
86GF Score
InBody Co Ltd XKRX:041830
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InBody Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ₩2,854 Mil mean?
InBody Co (XKRX:041830) has a Construction In Progress of ₩2,854 Mil as of Jun. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on InBody Co and its competitors.
Is InBody Co's Construction In Progress too high?
InBody Co's current Construction In Progress is ₩2,854 Mil. Overall, InBody Co has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does InBody Co's Construction In Progress compare to ABT and SYK?
InBody Co's Construction In Progress of ₩2,854 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on InBody Co and its competitors. InBody Co's current Construction In Progress is ₩2,854 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InBody Co stock overvalued right now?
Based on GuruFocus' analysis, InBody Co (XKRX:041830) is currently considered Significantly Overvalued. The stock's GF Value™ is ₩35,473.99, compared to a current price of ₩58,900.00 — trading 66% above its estimated fair value. The current Construction In Progress is ₩2,854 Mil. InBody Co's overall GF Score™ is 86/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For InBody Co (XKRX:041830), the current Construction In Progress is ₩2,854 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InBody Co (XKRX:041830) Overvalued in 2026?

Based on GuruFocus' analysis, InBody Co stock appears to be overvalued. The current stock price of ₩58,900.00 is trading 66% above its estimated GF Value™ of ₩35,473.99. GuruFocus considers InBody Co to be Significantly Overvalued.

Key valuation signals for XKRX:041830:

  • Construction In Progress: ₩2,854 Mil
  • GF Value™: ₩35,473.99 vs. price of ₩58,900.00 (66% above fair value)
  • GF Score™: 86/100 with 1 warning sign

No single metric tells the full story. See the XKRX:041830 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InBody Co Business Description

Address 54, Nonhyeon-ro 2-gil, Gangnam-gu, Seoul, KOR, 135-960
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.
86GF Score

Get the complete analysis for XKRX:041830

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₩58,900.00
Price
₩35,473.99
GF Value